Sep 12, 2022 / 06:50PM GMT
Shinichiro Muraoka - Morgan Stanley, Research Division - Research Analyst
We'll get start with our next session. I'm Shinichiro Muraoka of Morgan Stanley Japan Pharmaceutical team. And today, in this session with Takeda Pharmaceutical -- sorry, before starting that. So important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/disclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. So let's start. So today, we are with Andy Plump of -- President of R&D of Takeda; and Costa Saroukos, CFO. Thank you, Andy and Costa for joining us. Thank you.
Questions and Answers:
Shinichiro Muraoka - Morgan Stanley, Research Division - Research AnalystSo let's get start my question first to Costa about earnings for this year, next year and beyond. First, in this year, your last quarter earnings were quite good, not just with currency support, but quite good earnings. Could you -- I believe --